Investing
(TheNewswire) VANCOUVER, BC, September 23, 2024 Heritage Mining Ltd. (CSE: HML FRA:Y66) (‘ Heritage ‘ or the ‘ Company ‘) is pleased to announce the...
Hi, what are you looking for?
(TheNewswire) VANCOUVER, BC, September 23, 2024 Heritage Mining Ltd. (CSE: HML FRA:Y66) (‘ Heritage ‘ or the ‘ Company ‘) is pleased to announce the...
western copper and gold corporation (‘Western’ or the ‘Company’) (TSX: WRN) (NYSE American: WRN) welcomes the recent announcement by Natural Resources Canada (‘NRCan’), conditionally...
In Donald Trump’s imaginary world, Americans can’t venture out to buy a loaf of bread without getting shot, mugged or raped. Immigrants in a...
President Joe Biden will head to the United Nations General Assembly on Monday, seeking to cement his foreign policy legacy amid the growing threat...
Oil and gas industry leaders are skeptical of Vice President Kamala Harris’ stance on critical state issues and are calling for clarity on her...
Americans have increasingly soured on the Secret Service following the assassination attempt in July that wounded former president Donald Trump, according to a Gallup...
The US Department of Commerce and US Department of State have announced the inaugural meeting of the International Network of AI Safety Institutes, scheduled...
Commodities giant BHP (ASX:BHP,NYSE:BHP,LSE:BHP) announced on Wednesday (September 18) that it will partner with the Meewasin Valley Authority on efforts to conserve the Meewasin...
The S&P/TSX Venture Composite Index (INDEXTSI:JX) gained 35.21 points this week to close at 580.43. Meanwhile, the S&P/TSX Composite Index (INDEXTSI:OSPTX) was up 787.22...
Ukrainian President Volodymyr Zelensky toured a Pennsylvania ammunition plant on Sunday as he began a key visit to the United States in which he is expected to present...
ChemX Materials (ASX:CMX) (ChemX or the Company), an Australian high purity critical materials company and 100%-owner of the HiPurA® patented process to produce High...
Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that the Company’s Phase 2a clinical trial investigating narmafotinib in the...